Deficiency in PER proteins has no effect on the rate of spontaneous and radiation-induced carcinogenesis

Marina P Antoch1, Ilia Toshkov, Karen K Kuropatwinski

  • 1Department of Molecular and Cellular Biology; Roswell Park Cancer Institute; Buffalo, NY USA.

Insights

Circadian clock proteins PERIOD1 and PERIOD2 are not tumor suppressors. Gene deficiency in Per1 or Per2 does not increase cancer risk, and sex differences are crucial in radiation studies.

Area of Science:

  • Chronobiology
  • Cancer Biology
  • Genetics

Background:

  • Circadian clock components modulate signaling pathways and contribute to pathologies like cancer.
  • Mammalian PERIOD proteins were previously suggested as tumor suppressors, but evidence was inconsistent.

Purpose of the Study:

  • To systematically reevaluate the role of PERIOD proteins as tumor suppressors.
  • To investigate the impact of Per1 and Per2 gene deficiency on radiation-induced tumorigenesis in a sex-specific manner.

Main Methods:

  • Comparative analysis of tumor development in male and female wild-type, Per1(-/-), and Per2(-/-) mice after low-dose ionizing radiation.
  • Histopathological examination of radiation-induced tumors.

Main Results:

  • Per1 or Per2 gene deficiency alone did not increase tumor susceptibility.
  • Per2-deficient mice exhibited accelerated aging phenotypes rather than increased tumor proneness after radiation.
  • Significant sexual dimorphism was observed in radiation-induced tumorigenesis rates and tumor types.

Conclusions:

  • The role of PERIOD proteins as tumor suppressors requires reevaluation.
  • Sex-matched experimental groups are essential for in vivo studies investigating tumorigenesis and radiation effects.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair01:36

Mismatch Repair

Overview
Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
Spontaneous and Induced Mutations01:30

Spontaneous and Induced Mutations

Spontaneous mutations arise infrequently during DNA replication due to errors in the process. A key factor behind these errors is tautomeric shifts in nitrogenous bases, where bases transition from keto to enol forms or amino to imino forms. This shift can alter base-pairing rules, leading to mutations. Additionally, reactive oxygen species (ROS) arising from aerobic metabolism can damage DNA, resulting in depurination (loss of a purine base) or depyrimidination (loss of a pyrimidine base).